Nucleotide substitution: C?T.
Base change TCC->TTC.
Fmr1S174F.EP3517 carries both the P{EP} insertion present in the progenitor allele and the amino acid replacement in the Fmr1 coding region.
Amino acid replacement: S174F.
C10105629T
C?T
S174F | Fmr1-PA; S174F | Fmr1-PB; S174F | Fmr1-PC; S174F | Fmr1-PD; S136F | Fmr1-PE; S136F | Fmr1-PF; S222F | Fmr1-PG; S222F | Fmr1-PH; S136F | Fmr1-PI; S174F | Fmr1-PJ; S174F | Fmr1-PK
S174F
CyfipUAS.cSa, Fmr1S174F.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
CyfipUAS.cSa, Fmr1S174F.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
Co-overexpression of Fmr1S174F.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
Selected as: A mutation that suppresses the lethality caused when a Scer\GAL4 driver is used to overexpress Fmr1 from the P{EP}Fmr1EP3517 insertion.